Literature DB >> 3408982

Antibody titres to Campylobacter pylori after treatment for gastritis.

D Vaira1, J Holton, S R Cairns, M Falzon, A Polydorou, J F Dowsett, P R Salmon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3408982      PMCID： PMC1834287          DOI： 10.1136/bmj.297.6645.397

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate.

Authors:  C A McNulty; J C Gearty; B Crump; M Davis; I A Donovan; V Melikian; D M Lister; R Wise
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13

2.  Urease tests for Campylobacter pylori: care in interpretation.

Authors:  D Vaira; J Holton; S Cairns; A Polydorou; M Falzon; J Dowsett; P R Salmon
Journal:  J Clin Pathol       Date:  1988-07       Impact factor: 3.411

3.  Four hour rapid urease test (RUT) for detecting Campylobacter pylori: is it reliable enough to start treatment?

Authors:  D Vaira; J Holton; S Cairns; M Falzon; P Salmon
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

4.  Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia.

Authors:  B J Rathbone; J I Wyatt; B W Worsley; S E Shires; L K Trejdosiewicz; R V Heatley; M S Losowsky
Journal:  Gut       Date:  1986-06       Impact factor: 23.059
  4 in total
  19 in total

1.  Effect of antimicrobial therapy on the specific serological response to Helicobacter pylori infection.

Authors:  Y Glupczynski; A Burette; H Goossens; C DePrez; J P Butzler
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-07       Impact factor: 3.267

Review 2.  Infection and infectious diseases.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  1990-10       Impact factor: 2.401

3.  Elevated risk of Helicobacter pylori infection in submarine crews.

Authors:  I Hammermeister; G Janus; F Schamarowski; M Rudolf; E Jacobs; M Kist
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-01       Impact factor: 3.267

4.  Association between Helicobacter pylori infection and serum pepsinogen concentrations in gastroduodenal disease.

Authors:  K Matsumoto; N Konishi; M Ohshima; Y Hiasa; E Kimura; T Samori
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

5.  14C-urea breath test in C pylori gastritis.

Authors:  E A Rauws; E A Royen; W Langenberg; J V Woensel; A A Vrij; G N Tytgat
Journal:  Gut       Date:  1989-06       Impact factor: 23.059

6.  Serum pepsinogens as markers of response to therapy for Helicobacter pylori gastritis.

Authors:  F M Hunter; P Correa; E Fontham; B Ruiz; M Sobhan; I M Samloff
Journal:  Dig Dis Sci       Date:  1993-11       Impact factor: 3.199

7.  Evaluation of a commercial latex test for serological diagnosis of Helicobacter pylori infection in treated and untreated patients.

Authors:  A M Hirschl; M M Hirschl; J Berger; M L Rotter
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-11       Impact factor: 3.267

8.  Serological detection of Helicobacter pylori by a flow microsphere immunofluorescence assay.

Authors:  L M Best; S J Veldhuyzen van Zanten; G S Bezanson; D J Haldane; D A Malatjalian
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

9.  Long term serological surveillance after treatment of Helicobacter pylori infection.

Authors:  R A Veenendaal; A S Peña; J L Meijer; H P Endtz; M M van der Est; W van Duijn; F Eulderink; J Kreuning; C B Lamers
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

10.  Helicobacter pylori seroepidemiology in risk groups.

Authors:  A Quirós; E Quirós; I González; M C Bernal; G Piedrola; M C Maroto
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.